Gaspar Rosario, NP

Gaspar Rosario practices at NYU Pathology Associates in New York, New York.

Gaspar Rosario's NPI, 1639163470, was assigned on September 8, 2005. Gaspar Rosario holds New York license 304234.

Gaspar Rosario's primary practice is NYU Pathology Associates, at 530 First Ave Skirball Ste 7n, New York, NY 10016. The practice phone is (212) 263-5475.

Gaspar Rosario's primary practice is NYU Pathology Associates in New York, New York. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Gaspar Rosario to 1 more physician office and 1 group practice or clinic, each named with a free account. Gaspar Rosario's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Gaspar Rosario practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Gaspar Rosario's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dmand AI has Gaspar Rosario's licenses on file in 2 states: New York and New Jersey.

CMS data shows 223 Medicare services from Gaspar Rosario across 3 procedure codes in 2024, for 109 Medicare patients. Medicare paid $17,182 for them. Every service was in an office.

CMS counts 109 Medicare patients who saw Gaspar Rosario in 2024. The largest group is 65 to 74, with 66 patients. 75% of them have high cholesterol, and 61% have arthritis. Their average risk score is 0.88, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Gaspar Rosario's median patient age at 51, with 76% women.

In 2024, Gaspar Rosario wrote 244 Medicare Part D claims for 62 patients. CMS names the drug for 190 of them, across 4 drugs with 11 or more claims each, at $205,781 in total drug cost. In 2023, CMS named 218 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Gaspar Rosario for performance year 2024, reported as part of a group. Gaspar Rosario accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Gaspar Rosario as offering telehealth.

CMS Open Payments shows 114 general payments to Gaspar Rosario from 14 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $1,451.